Bula do remedy Pulmotrat

the package insert of the medicine Pulmotrat. Active principles Carbocisteina.

what For?

Mucolytic and fluidificante of secretions, treatment adjunct for disorders of acute and chronic respiratory tract, in which the secretions viscous and/or abundant mucus to be aggravating factor.

Contraindications

When should I not use?

The adverse reactions the most common manifest as discomfort gastrointestinal. Other reactions more rare include dry mouth, sensation of unpleasant taste, headache, dizziness, insomnia, atrial fibrillation, palpitations, discomfort in the epigastric, heartburn, nausea, vomiting, gastrointestinal bleeding, diarrhea, flatulence, rash, myalgia, convulsions, urinary incontinence, hypoglycemia.

Dosage

How to use?

PULMOTRAT syrup adult:
Adults and children over 12 years: 1 to ½ cup – measure (10 to 15ml), 3 (three) times a day. When the clinical response is obtained, reduce dose to ½ measuring cup (5ml), 3 (three) times a day.

PULMOTRAT syrup pediatric:
Children 2 to 5 years: ¼ to ½ cup measure (2.5 to 5ml), 3 (three) times a day.

Children 6 to 12 years: ½ to 1 cup – measured ( 5 to 10ml ), 3 (three) times a day.

Side Effects

What are the evils that can cause me?

The use of the PULMOTRAT is contraindicated in patients with active peptic ulcer, or hypersensitivity to the components of the formulation of PULMOTRAT.

Warnings and Precautions

what should I know before using?

PULMOTRAT should be used with caution in patients with a history of intestinal bleeding, peptic ulcer and function thyroid compromised. Although tests on animals mammals have not revealed teratogenic effects associated with the CARBOCISTEÍNA, there is no adequate data regarding the safety of use during pregnancy and lactation or in children less than 2 years of age, not being recommended for use in these cases.

be a minimum content of carbohydrates (10mg per 5ml), the product can be used by diabetic patients or submitted to the diet with restriction of carbohydrates.

have Not yet been established the efficacy and safety of use of the product in children less than 1 year.

Overdose

what to do if someone use a larger amount than is recommended?

In case of an overdose accidentally, seek medical advice immediately. Gastric lavage and supportive measures are recommended.

Introduction

Syrup adult: Bottle containing 100ml.

Syrup pediatric: Bottle containing 100ml.

Drug Interactions

Prepared on the basis of CARBOCISTEÍNA should not be administered concomitantly with agents antitussígenos and/or substances atropínicas.

DOSAGE
Were not reported to the interference of the drug on the result of the laboratory tests.

Introduction

Pulmotrat
Carbocisteína
Carbocisteína dcb: 0260.05-3

Compositions

Each 5ml syrup paediatric contains:
Carbocisteína 100mg.

Vehicle: deionized water, sugar, sodium benzoate, sodium carbonate, red dye, E. D. T. A disodium, essence of cherry, glycerin, sorbitol.

Each 5ml syrup adult contains:
Carbocisteína 250mg.

Vehicle: deionized water, sugar, sodium benzoate, sodium carbonate, red dye, E. D. T. A disodium, essence of cherry, glycerin , sorbitol.

Patient Info

PULMOTRAT it helps in the treatment of bronchitis and chronic obstructive pulmonary disease associated with mucus viscous or excessive facilitating the expectoration. It also assists in treatment of otitis media with effusion, and chronic otitis media.

– Care maintenance:
Conserve the product at room temperature (15-30ºC). Protect from light and moisture.

– Term of validity:
36 months from the manufacture date (SEE CARTRIDGE). Do not use medicine with the term of validity expired.

“Tell your doctor the occurrence of pregnancy during treatment or after its completion, and if you are breastfeeding,”.

“Follow the guidance of your doctor, always respecting the schedules, doses and duration of treatment”.

“do Not stop treatment without the knowledge of your doctor”.

“FOLLOW CORRECTLY THE MODE OF USE, NOT DISAPPEARING THE SYMPTOMS SEEK MEDICAL advice”.

The safety and effectiveness of the PULMOTRAT in children under the age of 1 year have not been established.

“Tell your doctor the appearance of reactions, which are unpleasant, such as: nausea, diarrhea, dizziness, gastrointestinal bleeding, allergic reactions, skin rashes or any other reactions to unpleasant during treatment.

To prescribe the product for diabetics is necessary to consider that each 5ml of syrup both adult and paediatric contains 2.5 g of sucrose.

“ALL MEDICINE SHOULD BE KEPT OUT of REACH OF CHILDREN”.

– Counter-Indications:
Active peptic ulcer, or hypersensitivity to the components of the formulation of PULMOTRAT .

– Precautions:
PULMOTRAT should be used with caution in patients with a history of intestinal bleeding, peptic ulcer and function thyroid committed.

Tell your doctor about any medicine you are using, before the beginning or during the treatment.

Although tests on animals mammals have not revealed teratogenic effects associated with the CARBOCISTEÍNA, there is no adequate data regarding the safety of use during pregnancy and lactation or in children less than 2 years of age, not being recommended for use in these cases.

be a minimum content of carbohydrates (10mg per 5ml), the product can be used by diabetic patients or submitted to the diet with restriction of carbohydrates.

“do NOT TAKE MEDICINE WITHOUT THE KNOWLEDGE OF YOUR DOCTOR, CAN BE HAZARDOUS TO YOUR HEALTH”.

Use In the Elderly

there are No recommendations or special care about the job in elderly patients.

Technical Information

PULMOTRAT presents, as an active principle, CARBOCISTEÍNA. This synthetic substance, derivative of cysteine, has demonstrated that it has activity mucolytic when administered by the oral route.

pharmacological Studies show that PULMOTRAT changes the rheological properties of mucus pathological, decreasing its viscosity and allowing its elimination by the sputum and by the moving cilia.

This occurs because of the particular mechanism of action of CARBOCISTEÍNA, active ingredient of PULMOTRAT , which acts by changing the synthesis composition of the mucus, reducing its viscosity by increasing the synthesis of sialomucinas.

Laboratory

the Industry

the REMEDY OF the EARTH

Privacy policy •
Who we Are •
Contact Us •
Bibliography

Attention: the remedy of The earth is a space character only, with issues related to health and well-being, The information here disclosed shall not be used as a substitute for a doctor’s prescription for the treatment of any disease.